Skip to main content

Table 2 Correlation between SOX2 expression and clinicopathological features of UCB patients

From: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2

Parameters Total

Group

Total

SOX2 expression

P value

High

Low

Gender

Male

79 (75%)

59 (56%)

20 (19%)

0.747

Female

27 (25%)

21 (20%)

6 (6%)

Age (years)

<  60

37 (35%)

25 (24%)

12 (11%)

0.166

≥ 60

69 (65%)

55 (52%)

14 (13%)

Tumor size (cm)

<  3 cm

42 (40%)

27 (25%)

15 (14%)

0.030 *

≥ 3 cm

64 (60%)

53 (50%)

11 (10%)

Multiplicity

Single

59 (56%)

42 (40%)

17 (16%)

0.251

Multiple

47 (44%)

38 (36%)

9 (8%)

Histological grade

Low grade

48 (45%)

30 (28%)

18 (17%)

0.005 **

High grade

58 (55%)

50 (47%)

8 (8%)

Tumor stage (T)

Ta, T1

26 (25%)

16 (15%)

10 (9%)

0.057

T2-T4

80 (75%)

64 (60%)

16 (15%)

Lymph nodes metastasis

NO

92 (87%)

69 (65%)

23 (22%)

0.772

YES

14 (13%)

11 (10%)

3 (3%)

  1. * P < 0.05; ** P < 0.01; P < 0.05 was considered significant